Article

HCPLive Webinar Series: The Health 2.0 Show

Join us February 29th for the second edition of the 2012 HCPLive Webinar Series. We're working with our friends at Health 2.0 to bring you an exciting and packed show that will focus on innovative tools for physicians including products that transform and aid in everything from scheduling to follow-up.

Join us February 29th for the second edition of the 2012 HCPLive Webinar Series. We’re working with our friends at Health 2.0 to bring you an exciting and packed show that will focus on innovative tools for physicians including products that transform and aid in everything from scheduling to follow-up. The presentation will feature three special guests who will discuss and demo their products:

  • Phil Carter, CEO, JiffPad
  • Daniel Kivatinos & Michael Nusimow, Co-founders, Dr. Chrono
  • Ben Chodor, CEO, Happtique
  • Steve Schelhammer, CEO, Phytel

Other agenda highlights include a news feature with the biggest stories and up-to-date news bites from Health 2.0’s very own Health2News.com. We hope that you will join us and please pass this information along to colleagues and friends!

Related Videos
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Tadashi Matsushita, MD, PhD: Reducing Treatment Burden in Hemophilia A With Mim8
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
Davide Matino, MD, MSc: Bringing Marstacimab Treatment to Hemophilia A and B
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
© 2024 MJH Life Sciences

All rights reserved.